{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:46:46Z","timestamp":1758476806958},"reference-count":39,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6289,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,5]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>JB\u20109322 is a selective histamine H<jats:sub>2<\/jats:sub>\u2010receptor antagonist with gastric antisecretory activity and mucosal protective properties.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The affinity of JB\u20109322 for the guinea\u2010pig atria histamine H<jats:sub>2<\/jats:sub>\u2010receptor was approximately 2 times greater than that of ranitidine.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p><jats:italic>In vivo<\/jats:italic>, the ID<jats:sub>50<\/jats:sub> value for the inhibition of gastric acid secretion in pylorus\u2010ligated rats was 5.28 mg kg<jats:sup>\u22121<\/jats:sup> intraperitoneally. JB\u20109322 also dose\u2010dependently inhibited gastric juice volume and pepsin secretion. In gastric lumen\u2010perfused rats, intravenous injection of JB\u20109322 dose\u2010dependently reduced histamine\u2010, pentagastrin\u2010 and carbachol\u2010stimulated gastric acid secretion.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>JB\u20109322 showed antiulcer activity against aspirin and indomethacin\u2010induced gastric lesions and was more potent than ranitidine.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>JB\u20109322 effectively inhibited macroscopic gastric haemorrhagic lesions induced by ethanol. Intraperitoneal injection was effective in preventing the lesions as well as oral treatment. The oral ID<jats:sub>50<\/jats:sub> value for these lesions was 1.33 mg kg<jats:sup>\u22121<\/jats:sup>. By contrast, ranitidine (50 mg kg<jats:sup>\u22121<\/jats:sup>) failed to reduce these lesions. In addition, the protective effect of JB\u20109322 was independent of prostaglandin synthesis.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>These results indicate that JB\u20109322 is a new antiulcer drug that exerts a potent cytoprotective effect in addition to its gastric antisecretory activity.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1995.tb16319.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T05:28:04Z","timestamp":1342762084000},"page":"57-66","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["JB\u20109322, a new selective histamine H<sub>2<\/sub>\u2010receptor antagonist with potent gastric mucosal protective properties"],"prefix":"10.1111","volume":"115","author":[{"given":"Beatriz","family":"Palacios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Jose","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma Angeles","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis San","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1980.tb14555.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.22.1.79"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1959.tb00928.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/236385a0"},{"key":"e_1_2_1_6_1","first-page":"464P","article-title":"Ranitidine (AH 19065): a new potent, selective histamine H2\u2010receptor antagonist","volume":"66","author":"BRADSHAW J.","year":"1979","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198312001-00007"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/0016-5085(78)90697-2","article-title":"Cimetidine and prostaglandin: evidence for different modes of action on the rat gastric mucosa","volume":"74","author":"CARMICHAEL H.A.","year":"1978","journal-title":"Gastroenterology"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb09103.x"},{"key":"e_1_2_1_10_1","first-page":"415","article-title":"Actualit\u00e9 des antagonistes des r\u00e9cepteurs H2 dans le traitement de l'ulc\u00e8re","volume":"55","author":"DEBONGNIE J.C.","year":"1992","journal-title":"Acta Gastroenterol. Belg."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90677-0"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1958.tb00190.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198937060-00003"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90543-Y"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.33.020182.001151"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296616"},{"key":"e_1_2_1_17_1","first-page":"1078","article-title":"Antisecretory and antilesional effect of a new histamine H2\u2010receptor antagonist, IT\u2010066, in rats","volume":"255","author":"ISOBE Y.","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.29.670"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00027a007"},{"key":"e_1_2_1_20_1","first-page":"404","article-title":"Pharmacology of ORF 17578, a new histamine H2\u2010receptor antagonist: comparison with cimetidine and ranitidine","volume":"237","author":"KATZ L.B.","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_21_1","first-page":"587","article-title":"Pharmacological comparison of ORF 17910, a potent, long\u2010acting histamine H2\u2010receptor antagonist, to cimetidine and ranitidine","volume":"238","author":"KATZ L.B.","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_22_1","first-page":"22","volume-title":"Drug Invest., 2","author":"KUWAYAMA H.","year":"1990"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0016-5085(82)80071-1","article-title":"Salicilic acid blocks indomethacin\u2010 and aspirin\u2010induced cyclo\u2010oxigenase inhibition in rat gastric mucosa","volume":"83","author":"LIGUMSKY M.","year":"1982","journal-title":"Gastroenterology"},{"key":"e_1_2_1_24_1","first-page":"114","article-title":"Gastric antisecretory and cytoprotective activities of SCH 28080","volume":"226","author":"LONG J.F.","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00345a002"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01078346"},{"key":"e_1_2_1_27_1","article-title":"JB\u20109322, un piperidino\u2010metilfenoxipropilamino derivado, con propiedades gastroprotectoras","volume":"4","author":"PALACIOS B.","year":"1993","journal-title":"Abstract Book of the VIII Congress of the Spanish Society of Therapeutic Chemistry"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02205240"},{"key":"e_1_2_1_29_1","first-page":"G113","article-title":"Mild irritants prevent gastric necrosis through adaptive cytoprotection mediated by prostaglandins","volume":"245","author":"ROBERT A.","year":"1983","journal-title":"Am. J. Physiol."},{"key":"e_1_2_1_30_1","first-page":"433","article-title":"Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HC1, NaOH, hypertonic NaCl and thermal injury","volume":"77","author":"ROBERT A.","year":"1979","journal-title":"Gastroenterology"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00402a039"},{"key":"e_1_2_1_32_1","first-page":"129","article-title":"Pharmacological profiles of the new histamine H2\u2010receptor antagonist N\u2010ethyl\u2010N'\u2010[3\u2010[3\u2010(piperidinomethyl)\u2010phenoxy]propyl]urea","volume":"43","author":"SEKIGUCHI H.","year":"1993","journal-title":"Arzneim. Forsch."},{"key":"e_1_2_1_33_1","first-page":"134","article-title":"Effects of the new histamine H2\u2010receptor antagonist N\u2010ethyl\u2010N'\u2010[3\u2010[3\u2010(piperidino\u2010methyl)phenoxy]propyl]urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats","volume":"43","author":"SEKIGUCHI H.","year":"1993","journal-title":"Arzneim. Forsch."},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0950-3528(93)90030-V"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-192304000-00006"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.54.277"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.45.97"},{"key":"e_1_2_1_38_1","first-page":"734","article-title":"Effect of a new H2\u2010blocker, 3\u2010[[[2\u2010[(diaminomethylene)amino]\u20104\u2010thiazol\u2010yl]methyl]thio]\u2010N2sulfamoyl propionamide (YM\u201011170), on gastric secretion, ulcer formation and weight of male accessory sex organs in rats","volume":"32","author":"TAKEDA M.","year":"1982","journal-title":"Arzneim. Forsch."},{"key":"e_1_2_1_39_1","volume-title":"Manual of Pharmacologic Calculations with Computer Programs","author":"TALLARIDA R.J.","year":"1984"},{"key":"e_1_2_1_40_1","first-page":"514","article-title":"Apparent irreversible H2\u2010receptor blocking and prolonged gastric antisecretory activities of 3\u2010N\u2010{3\u2010[3\u2010(l\u2010piperidino\u2010methyl) phenoxy]propyl] amino\u20104\u2010amino\u20101, 2, 5\u2010thia\u2010diazole\u2010l\u2010oxide (L\u2010643,441)","volume":"224","author":"TORCHIANA M.L.","year":"1983","journal-title":"J, Pharmacol. Exp. Ther."}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb16319.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb16319.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:15:08Z","timestamp":1698369308000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb16319.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb16319.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16319.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}